Extended (Alternate Day) Antipsychotic Dosing
Re-examining Maintenance Antipsychotic Treatment in Schizophrenia: Extended Antipsychotic Dosing
Sponsor: Centre for Addiction and Mental Health
This PHASE4 trial investigates Antipsychotic Agents and Drug Administration Schedule and is currently actively recruiting participants. Centre for Addiction and Mental Health leads this study, which shows 13 recorded versions since 2022 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
13 versions recorded-
Jun 2025 — Present [monthly]
Recruiting PHASE4
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 8 earlier versions
-
Feb 2023 — Oct 2023 [monthly]
Recruiting PHASE4
-
Sep 2022 — Feb 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE4
-
Sep 2021 — Apr 2022 [monthly]
Not Yet Recruiting PHASE4
-
Feb 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE4
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre for Addiction and Mental Health
For direct contact, visit the study record on ClinicalTrials.gov .